Literature DB >> 16234679

Tumors of the lateral and third ventricle: removal under endoscope-assisted keyhole conditions.

Patra Charalampaki1, Ronald Filippi, Stefan Welschehold, Jens Conrad, Axel Perneczky.   

Abstract

OBJECTIVE: Intraventricular tumors usually are managed by approaches and microsurgical techniques that need retraction and dissection of important brain structures. Minimally invasive endoscopic procedures achieve a remarkable alternative to conventional microneurosurgical techniques. Endoscope-assisted microneurosurgery may be a minimally invasive technique with maximally effective treatment. Using the keyhole concept for planning the surgical strategy, the reduction of the brain retraction is achieved, which is one of the main benefits of this technique.
METHODS: We treated 35 patients (16 female patients and 19 male patients) with tumors in the lateral (n = 8) and the third (n = 27) ventricle. Patient age at the date of surgery ranged from 5 to 73 years. The follow-up period ranged from 6 to 83 months. The tumors were operated on using transcortical, transcallosal, or suboccipital transtentorial or infratentorial supracerebellar approaches after precise planning of the skin incision, the trephination, and the trajectory to the center of the tumor, performed earlier with a magnetic resonance imaging scan.
RESULTS: Total removal of the tumor was achieved in 28 patients (78.5%). In 2 patients (6.5%), recurrent tumor occurred. In 5 patients (15%), parts of the tumors remained because of infiltration of eloquent areas. Overall clinical improvement was achieved in 31 patients (87%). Three patients (10%) were unchanged and 1 patient (3%) deteriorated.
CONCLUSION: Endoscope-assisted keyhole neurosurgery seems to be a safe method of removing tumors in all regions inside the ventricular system with a low risk of permanent neurological deficits. The exact surgical corridor planning on the basis of the keyhole strategy offers less traumatic exposure of even deep-seated endoventricular tumors.

Entities:  

Mesh:

Year:  2005        PMID: 16234679     DOI: 10.1227/01.neu.0000176638.86772.2d

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Dry-field maneuver for controlling the massive intraventricular bleeding during neuroendoscopic procedures.

Authors:  Tuncer Turhan
Journal:  Childs Nerv Syst       Date:  2017-11-09       Impact factor: 1.475

2.  The ipsilateral interhemispheric transprecuneal approach: microsurgical anatomy, indications, and neurosurgical applications.

Authors:  Lorenzo Pescatori; Maria Pia Tropeano; Pasqualino Ciappetta
Journal:  Neurosurg Rev       Date:  2020-02-08       Impact factor: 3.042

3.  Vascular Decompression of Trigeminal and Facial Nerves in the Posterior Fossa under Endoscope-Assisted Keyhole Conditions.

Authors:  P Charalampaki; A M Kafadar; P Grunert; A Ayyad; A Perneczky
Journal:  Skull Base       Date:  2008-03

4.  An endoscopic-assisted technique for retrosellar access during the extended retrosigmoid approach: a cadaveric feasibility study and quantitative analysis of retrosellar working area.

Authors:  Varun R Kshettry; Silky Chotai; William Chen; Jun Zhang; Mario Ammirati
Journal:  Neurosurg Rev       Date:  2013-12-18       Impact factor: 3.042

5.  [Endoscopic transnasal surgery for pituitary adenomas].

Authors:  Pablo Ajler; Santiago Hem; Ezequiel Goldschmidt; Federico Landriel; Alvaro Campero; Claudio Yampolsky; Antonio Carrizo
Journal:  Surg Neurol Int       Date:  2012-12-08

Review 6.  International expert consensus statement about methods and indications for keyhole microneurosurgery from International Society on Minimally Invasive Neurosurgery.

Authors:  Qing Lan; Michael Sughrue; Nikolai J Hopf; Kentaro Mori; Jaechan Park; Hugo Andrade-Barazarte; Mangaleswaran Balamurugan; Macro Cenzato; Giovanni Broggi; Dezhi Kang; Kenichiro Kikuta; Yuanli Zhao; Hengzhu Zhang; Shinsuke Irie; Yuping Li; Boon Seng Liew; Yoko Kato
Journal:  Neurosurg Rev       Date:  2019-11-21       Impact factor: 3.042

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.